Transforming Healthcare with Evidence

hayesinfo@hayesinc.com | 215-855-0615

I consider Hayes to be the gold standard when it comes to the research and analysis of new medical technologies.

Current Client

GTE Topics for Pharmacogenetic

Topic GTE Synopsis GTE Report
CYP2D6 Genotyping for Tamoxifen
CYP450 Genotyping to Predict Response to Antipsychotic Drugs Pending
HERmark Breast Cancer Assay Pending
HLA-B*5701 Testing for Abacavir Hypersensitivity
Ki-67 (MKI67) Proliferation Marker Testing in Breast Cancer Pending
Oncotype DX (Breast Cancer)
DecisionDx-GBM Pending
PGxPredict Rituximab
PREZEON PTEN Gene Expression Test N/A *
PTEN Gene Expression Testing
ResponseDX: Colon N/A *
TOP2A Testing to Predict Treatment Response in Breast Cancer


* Indicates insufficient evidence for full report.

Stay Connected!

To receive webinar announcements, email newsletters, updates, and special offers from Hayes, click here to join our mailing lists.

Social Media